ArticleMicrobial cell factories2026
Optimization of an improved chemically defined medium for high-efficiency expression of glucokinase in Escherichia coli.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundRecombinant glucokinase (GLK), an important enzyme for blood glucose diagnostics, is commonly prepared in Escherichia coli (E.coli )for laboratory research and related biosynthetic applications. In small-scale laboratory cultivation, complex media are often used because of their convenience and strong growth-supporting capacity, but their ill-defined composition and batch-to-batch variability can compromise reproducibility and increase medium-related costs. Although minimal defined medium (e.g., M9 medium) are generally preferred in scalable E. coli bioprocesses because of their compositional consistency and process controllability, their relatively simple nutrient composition may limit recombinant protein expression performance under laboratory-scale conditions. Therefore, developing an improved chemically defined medium represents a practical strategy to balance expression efficiency, compositional control, and medium cost for recombinant GLK production.
resultsTo address this, we developed a chemically defined medium including amino acids using high-throughput respiration activity monitoring system (RAMOS) and a high-throughput growth curve analysis system (Growth Profiler 960, GP960), alongside a machine learning-driven iterative optimization system (Machine-learning guided Experimental Trials for Improvement of Systems, METIS). The optimized medium enhanced soluble GLK expression by 33 fold compared to the pre-optimization medium, reaching 74% of the titer obtained in complex media, while reducing medium costs by 74%. Moreover, soluble protein expression per cell increased by 80% compared to the complex medium, lowering the medium usage cost per unit of bacterial protein by 85%. Validation in a 7.5 L bioreactor demonstrated that the optimized medium supported continuous growth to an optical density at 600 nm (OD
conclusionThis study tackles the challenge of suboptimal media in GLK fermentation, offering a cost-effective alternative and a transferable strategy for optimizing fermentation processes for other high-value enzymes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.